New York, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (Lirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced...
Lirum Therapeutics Announces Positive Data on LX-101
New York, NY, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (œLirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases,...
New York, NY, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (œLirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases,...
Lirum Therapeutics Presents Positive Data on LX-101
New York, NY, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (œLirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases,...
NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (œLirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, today...